Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals [clinicaltrials:NCT00001997]
Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals [clinicaltrials:NCT00001997]
Bio2RDF identifier
NCT00001997
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00001997
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
To investigate the safe ...... nical markers of HIV disease.
brief title [clinicaltrials_vocabulary:brief-title]
Safety and Efficacy of Polyeth ...... ic and Symptomatic Individuals
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Four escalating doses o ...... hour after subsequent doses.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Didanosine
Interleukin-2
Polyethylene Glycols
Recombinant Proteins
Zidovudine
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2005-06-23T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00001997
official title [clinicaltrials_vocabulary:official-title]
Safety and Efficacy of Polyeth ...... ic and Symptomatic Individuals
org study id [clinicaltrials_vocabulary:org-study-id]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
secondary id [clinicaltrials_vocabulary:secondary-id]
CS-PG91-07
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
1991-07-01T00:00:00Z
identifier
clinicaltrials:NCT00001997
title
Safety and Efficacy of Polyeth ...... ic and Symptomatic Individuals
@en
type
label
Safety and Efficacy of Polyeth ...... s [clinicaltrials:NCT00001997]
@en